Clinical Trial Update: High Dose CVVHDF Compared to Standard Dose CVVHDF [Phase 3]

View source ↗

Summary

This Phase 3 trial compares high-dose CVVHDF to standard-dose CVVHDF in acute kidney injury and has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• CVVHDF therapy (continuous venovenous hemodiafiltration)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Acute Renal Failure | Phase 3 | Status: COMPLETED | Results posted: 2010-03-12